# Safety and Initial Feasibility of Using the Neurolyser XR Device for the Treatment of Axial Chronic Low Back Pain

> **NCT04129034** · NA · UNKNOWN · sponsor: **FUSMobile Inc.** · enrollment: 30 (actual)

## Conditions studied

- Facet Syndrome of Lumbar Spine

## Interventions

- **DEVICE:** Neurolyser XR

## Key facts

- **NCT ID:** NCT04129034
- **Lead sponsor:** FUSMobile Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-24
- **Primary completion:** 2022-10-26
- **Final completion:** 2023-03-26
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04129034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04129034, "Safety and Initial Feasibility of Using the Neurolyser XR Device for the Treatment of Axial Chronic Low Back Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04129034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*